ARCHIVES

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

This article is from The Cancer Letter archive.

Vol. 36 No. 24 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

Fox Chase Biochemist Automates DNA Production

July 20, 1990

ASBMT Installs New Officers

March 14, 2003

Book By Clinical Researcher Makes Case For Nationwide Reforms

July 30, 1993

NCI CTEP Approved Trials For the Month of January

January 31, 2014

NCI Programs: HMO Research Network wins $16 Million Grant for Prevention Studies

July 30, 1999

Cancer Control Reps Discuss Issues of ‘80s

October 17, 1980